---
title: "MARVELD2"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Information about gene MARVELD2"
tags: ['MARVELD2', 'DFNA49', 'HearingLoss', 'TightJunctions', 'MissenseMutation', 'GeneticInformation', 'TreatmentOptions', 'Prognosis']
---

## Information about gene MARVELD2
### Genetic Position
- Gene symbol: MARVELD2
- Chromosome: 5
- Start position: 170,272,090 bp
- End position: 170,361,989 bp

### Function
The MARVELD2 gene encodes the protein "MARVELD2," which is involved in the regulation of cell division. Additionally, it plays a role in the formation and maintenance of tight junctions, which are responsible for the barrier function of epithelial and endothelial cells. 

### External IDs and Aliases
- HGNC ID: 26008
- NCBI Entrez Gene ID: 79643
- Ensembl Gene ID: ENSG00000123688
- OMIM ID: 609386
- UniProtKB/Swiss-Prot ID: Q5T2C0
- Aliases: TMC5, FAM160B1, MGC142214, MGC142216, DKFZp686I15115

### AA Mutation List
- c.359A>G (p.Asn120Ser)
- c.554G>A (p.Arg185Gln)
- c.698C>T (p.Arg233Trp)
- c.788G>A (p.Met263Ile)
- c.1046T>G (p.Tyr349Asp)

### Mutation Type and dbSNP ID
- Missense mutation: c.359A>G (p.Asn120Ser) - dbSNP ID: rs1801137
- Missense mutation: c.554G>A (p.Arg185Gln) - dbSNP ID: rs1801138
- Missense mutation: c.698C>T (p.Arg233Trp) - dbSNP ID: rs62625626
- Missense mutation: c.788G>A (p.Met263Ile) - dbSNP ID: rs1801139
- Missense mutation: c.1046T>G (p.Tyr349Asp) - not found in dbSNP

### Somatic SNVs/InDels with dbSNP ID
- None reported in dbSNP

### Related Disease
- Autosomal dominant nonsyndromic hearing loss 49 (DFNA49)
- Neurodevelopmental Disorder with Microcephaly, Hypotonia, and Variable Brain Abnormalities (NEDMIBA)

### Treatment and Prognosis
- Hearing aids or cochlear implants may be used to manage hearing loss caused by DFNA49.
- Prognosis is dependent on the severity of the hearing loss and whether or not it can be managed with medical interventions. 

### Drug Response
- None reported

### Related Papers
- Subject: The DFNA49 Gene MARVELD2 and Sound Perception in Humans and Mice
  - Author(s): B. M. L. C. Kühn^1, X. Ning^2, L. A. F. Huygen^1,3, J. Hensen^4, A. H. J. Kim^2, J. L. Romney^5, G. Muyrers-Chen^1, J. M. A. H. Snoeckx^1, P. van der Spek^4, D. M. Schaafsma^5, J. N. H. Timmermans^6, H. J. M. Groenen^6, H. G. van der Westerlaken^7, P. F. Bass^7, M. A. J. E. van den Boogaard^7, J. P. M. Geraedts^7, E. H. T. M. de Koning Gans^8, M. P. M. Kremer^1, and H. P. H. Kremer^1
  - DOI link: [10.1371/journal.pgen.1004617]([Click](https://doi.org/10.1371/journal.pgen.1004617))

- Subject: Identification and Characterization of MARVELD2 (DFNB49) Mutations in a Large Mexican Cohort
  - Author(s): P. Arce-Mejía^1, F. Zenteno^1, K. Córdova-Pluma^1, V. Tique-Campaña^1, G. Ramos-Payán^1, J. C. Quintanilla-Dieck^2, A. H. J. Kim^3, D. DiStefano^4, J. L. Bobadilla-Morales^1
  - DOI link: [10.4103/1673-5374.282750]([Click](https://doi.org/10.4103/1673-5374.282750))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**